KIR3DL1 Antibodies

Santa Cruz Biotechnology features a diverse variety of KIR3DL1 monoclonal antibodies for research in understanding the role of this important immune receptor. KIR3DL1 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KIR3DL1, a member of the killer immunoglobulin-like receptor (KIR) family, plays a crucial role in the regulation of natural killer (NK) cell activity and the immune response. KIR3DL1 is involved in the recognition of specific ligands on target cells, influencing the balance between activation and inhibition of NK cells. Understanding KIR3DL1's function provides valuable insights into immune evasion by tumors and the development of autoimmune diseases. Research focused on KIR3DL1 continues to reveal new aspects of immune system regulation and potential therapeutic targets. Investigating KIR3DL1 expression patterns helps scientists better understand NK cell development and function. The specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of immune system regulation and disease mechanisms.